Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.

Saved in:
Bibliographic Details
Title: Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.
Authors: Châtel-Soulet HÉ; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland., Juge S; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland., Pereira AL; Department of Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland., Seguin J; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics (SIB), Basel, Switzerland., El Taher A; Swiss Institute of Bioinformatics (SIB), Basel, Switzerland.; Bioinformatics Core Facility, University of Basel, Basel, Switzerland., Valigi F; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland., Jevtic Z; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland., Sivalingam R; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland., Bagger FO; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Büschl P; Department of Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland., Almosailleakh M; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.; Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Tzankov A; Institute for Pathology, University of Basel, Basel, Switzerland., Tong W; Division of Haematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Kurokawa M; Department of Haematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan., Nombela Arrieta C; Department of Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland., Schwaller J; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland. J.Schwaller@unibas.ch.
Source: Nature communications [Nat Commun] 2025 Dec 19; Vol. 17 (1), pp. 892. Date of Electronic Publication: 2025 Dec 19.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41419472
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Châtel-Soulet+HÉ%22">Châtel-Soulet HÉ</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Juge+S%22">Juge S</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pereira+AL%22">Pereira AL</searchLink>; Department of Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Seguin+J%22">Seguin J</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics (SIB), Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22El+Taher+A%22">El Taher A</searchLink>; Swiss Institute of Bioinformatics (SIB), Basel, Switzerland.; Bioinformatics Core Facility, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Valigi+F%22">Valigi F</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jevtic+Z%22">Jevtic Z</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sivalingam+R%22">Sivalingam R</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bagger+FO%22">Bagger FO</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Büschl+P%22">Büschl P</searchLink>; Department of Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Almosailleakh+M%22">Almosailleakh M</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland.; Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Tzankov+A%22">Tzankov A</searchLink>; Institute for Pathology, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tong+W%22">Tong W</searchLink>; Division of Haematology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kurokawa+M%22">Kurokawa M</searchLink>; Department of Haematology and Oncology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nombela+Arrieta+C%22">Nombela Arrieta C</searchLink>; Department of Medical Oncology and Haematology, University Hospital Zürich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schwaller+J%22">Schwaller J</searchLink>; University Children's Hospital & Department of Biomedicine, University of Basel, Basel, Switzerland. J.Schwaller@unibas.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Dec 19; Vol. 17 (1), pp. 892. <i>Date of Electronic Publication: </i>2025 Dec 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41419472
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-67611-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 892
    Titles:
      – TitleFull: Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Châtel-Soulet HÉ
      – PersonEntity:
          Name:
            NameFull: Juge S
      – PersonEntity:
          Name:
            NameFull: Pereira AL
      – PersonEntity:
          Name:
            NameFull: Seguin J
      – PersonEntity:
          Name:
            NameFull: El Taher A
      – PersonEntity:
          Name:
            NameFull: Valigi F
      – PersonEntity:
          Name:
            NameFull: Jevtic Z
      – PersonEntity:
          Name:
            NameFull: Sivalingam R
      – PersonEntity:
          Name:
            NameFull: Bagger FO
      – PersonEntity:
          Name:
            NameFull: Büschl P
      – PersonEntity:
          Name:
            NameFull: Almosailleakh M
      – PersonEntity:
          Name:
            NameFull: Tzankov A
      – PersonEntity:
          Name:
            NameFull: Tong W
      – PersonEntity:
          Name:
            NameFull: Kurokawa M
      – PersonEntity:
          Name:
            NameFull: Nombela Arrieta C
      – PersonEntity:
          Name:
            NameFull: Schwaller J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 12
              Text: 2025 Dec 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1